Literature DB >> 8990179

A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA.

W Dietrich-Goetz1, I M Kennedy, B Levins, M A Stanley, J B Clements.   

Abstract

Papillomavirus late gene expression is tightly linked to the differentiation state of the host cell. Levels of late mRNAs are only in part controlled by regulation of the late promoter, other posttranscriptional mechanisms exist that reduce the amount of late mRNA in undifferentiated cells. Previously we described a negative regulatory element (NRE) located upstream of the human papillomavirus type 16 late poly(A) site. We have delineated the NRE to a 79-nt region in which a G+U-rich region was the major determinant of NRE activity. UV-crosslinking assays identified a prominent nuclear protein of 65 kDa as the only factor in close contact with the NRE, and a complex of at least five proteins, including the 65-kDa protein, was enriched on NRE-RNA. Binding of the 65-kDa protein was depleted by preincubation with poly(U) Sepharose in high salt, a property characteristic of the U2 small nuclear ribonucleoprotein auxiliary factor U2AF65 and bacterially expressed U2AF65 exhibited NRE binding. The 65-kDa protein bound to the G+U-rich NRE 3' half which shows homology to the B2P2 sequence a known U2AF65 binding site in the alpha-tropomyosin gene, and the G+U-rich element can be replaced by B2P2 in the binding assay. Treatment of cells with phorbol 12-myristate 13-acetate reduced binding of the 65-kDa protein, induced NRE binding of a cytoplasmic protein, and relieved the NRE block on reporter gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990179      PMCID: PMC19268          DOI: 10.1073/pnas.94.1.163

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon.

Authors:  B E Hoffman; P J Grabowski
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

2.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

Review 3.  What determines the instability of c-myc proto-oncogene mRNA?

Authors:  I A Laird-Offringa
Journal:  Bioessays       Date:  1992-02       Impact factor: 4.345

4.  RNA annealing activity is intrinsically associated with U2AF.

Authors:  C G Lee; P D Zamore; M R Green; J Hurwitz
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

5.  Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer.

Authors:  S T Cole; R E Streeck
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

7.  Regulation of herpes simplex virus poly (A) site usage and the action of immediate-early protein IE63 in the early-late switch.

Authors:  F McGregor; A Phelan; J Dunlop; J B Clements
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

Authors:  S T Cole; O Danos
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

9.  The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies.

Authors:  I Pettersson; M Hinterberger; T Mimori; E Gottlieb; J A Steitz
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

10.  Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation.

Authors:  M A Bedell; J B Hudson; T R Golub; M E Turyk; M Hosken; G D Wilbanks; L A Laimins
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more
  20 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Inhibitory cis-element-mediated decay of human papillomavirus type 16 L1-transcript in undifferentiated cells.

Authors:  Seiichiro Mori; Saori Ozaki; Toshiharu Yasugi; Hiroyuki Yoshikawa; Yuji Taketani; Tadahito Kanda
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

Review 3.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

4.  The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein.

Authors:  M Sokolowski; H Furneaux; S Schwartz
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 5.  Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes.

Authors:  S Ogbourne; T M Antalis
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.

Authors:  Xiaohong Wang; Craig Meyers; Hsu-Kun Wang; Louise T Chow; Zhi-Ming Zheng
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

7.  The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.

Authors:  M D Koffa; S V Graham; Y Takagaki; J L Manley; J B Clements
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

8.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

Authors:  Z M Zheng; M Huynen; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.

Authors:  Xiaomin Zhao; Margaret Rush; Stefan Schwartz
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex.

Authors:  Sarah A Cumming; Maria G McPhillips; Thanaporn Veerapraditsin; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.